Rare diseases
Investigational molecules
Locations
Back to Bulgaria27 clinical trials in Kyustendil, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
BulgariaStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
BulgariaStudy of PF-07328948 tablets compared to placebo in adults with heart failure to evaluate effects on symptoms and physical function
BulgariaStudy on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
BulgariaRandomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function
BulgariaEvaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function
BulgariaBulgariaKAI-9531 in Adults With Obesity or Overweight and Diabetes
BulgariaStudy on the Effectiveness and Safety of IVX-A12 Vaccine for Preventing Respiratory Infections in Adults Aged 60 and Older
BulgariaStudy of linaprazan glurate and lansoprazole to maintain healing in patients with erosive esophagitis caused by acid reflux disease
BulgariaA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
BulgariaComparison of linaprazan glurate versus lansoprazole for healing of erosive esophagitis in adults with gastroesophageal reflux disease
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on respiratory syncytial virus (RSV) and human metapneumovirus infections, with trials evaluating novel vaccine technologies and therapeutic interventions for adults and at-risk populations.
Studies include assessment of advanced therapeutics like EDP-938 for acute infections.
Groundbreaking studies examining atherosclerotic cardiovascular disease prevention and treatment, with particular focus on innovative therapies to reduce major adverse cardiovascular events.
Clinical trials evaluating inclisiran's effectiveness in preventing heart attacks and strokes.
Comprehensive research into thalassemia and related blood disorders, investigating new treatments for both transfusion-dependent and non-transfusion-dependent patients.
Trials include evaluation of mitapivat and novel therapeutic approaches for blood disorders.
Advanced research targeting hypertriglyceridemia, including severe forms, with trials evaluating innovative treatments for lipid management.
Multiple studies examining plozasiran's effectiveness in treating various forms of hypertriglyceridemia.
Important research in childhood immunization, focusing on the development and safety assessment of vaccines for common childhood diseases.
Studies include evaluation of chickenpox vaccine safety in young children.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
